**1. Introduction**

Myopic traction maculopathy was first described by Panozza and associates in 2004 as a group of pathological features seen in eyes with high myopia generated by traction [1]. In recent times, MTM is also termed as myopic foveoschisis. One of the important reasons for reduced vision in these myopic eyes is traction-related retinal disorders. Eyes with myopic traction maculopathy demonstrate features of vitreomacular traction, retinal thickening, macular retinal schisis-like thickening, lamellar macular hole (MH), and foveal retinal detachment (FRD)[2]. Many of these retinal pathologies are not detectable on clinical examination and are only found on advanced imaging with optical coherence tomography. Because of the clinical subtlety of some of these disorders, decreased visual acuity may be attributed to other causes, whereas macular traction may remain undiagnosed [3–8]. The natural course of myopic macular traction disorders is not clear. Some studies have shown progression to more serious complications like full-thickness MH and FRD while a few studies have shown spontaneous resolution of foveal detachment and macular retinoschisis after development of spontaneous posterior vitreous detachment (PVD) [6, 9–13]. Optical coherence tomography (OCT) is a useful, non-invasive and indispensable tool in the diagnosis, pathogenesis, staging, prognosis, treatment and follow-up of MTM. In this article, we describe the role of OCT imaging in MTM.
